nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP3A4—Everolimus—kidney cancer	0.101	0.26	CbGbCtD
Felbamate—CYP3A4—Temsirolimus—kidney cancer	0.068	0.176	CbGbCtD
Felbamate—CYP2C19—Sorafenib—kidney cancer	0.0429	0.111	CbGbCtD
Felbamate—CYP3A4—Pazopanib—kidney cancer	0.0357	0.0924	CbGbCtD
Felbamate—CYP3A4—Erlotinib—kidney cancer	0.0255	0.0659	CbGbCtD
Felbamate—CYP3A4—Paclitaxel—kidney cancer	0.0233	0.0603	CbGbCtD
Felbamate—CYP3A4—Sorafenib—kidney cancer	0.0207	0.0536	CbGbCtD
Felbamate—CYP3A4—Vinblastine—kidney cancer	0.0205	0.0529	CbGbCtD
Felbamate—CYP3A4—Vincristine—kidney cancer	0.0201	0.052	CbGbCtD
Felbamate—CYP3A4—Sunitinib—kidney cancer	0.0168	0.0434	CbGbCtD
Felbamate—CYP3A4—Doxorubicin—kidney cancer	0.0126	0.0325	CbGbCtD
Felbamate—Lacosamide—CA9—kidney cancer	0.00235	0.527	CrCbGaD
Felbamate—Lacosamide—CA2—kidney cancer	0.00211	0.474	CrCbGaD
Felbamate—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000353	0.00505	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—MAPK1—kidney cancer	0.00035	0.00501	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—KDR—kidney cancer	0.000335	0.00479	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CER1—kidney cancer	0.000325	0.00466	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—kidney cancer	0.000322	0.00462	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—ACHE—kidney cancer	0.000321	0.0046	CbGpPWpGaD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CA—kidney cancer	0.000317	0.00455	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BCHE—kidney cancer	0.00031	0.00445	CbGpPWpGaD
Felbamate—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000302	0.00433	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS1—kidney cancer	0.000302	0.00433	CbGpPWpGaD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000302	0.00432	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000301	0.00431	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EPAS1—kidney cancer	0.000294	0.00421	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HNF1A—kidney cancer	0.000294	0.00421	CbGpPWpGaD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000291	0.00417	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BCHE—kidney cancer	0.00028	0.00401	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.00028	0.004	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000274	0.00393	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—ACHE—kidney cancer	0.000273	0.00391	CbGpPWpGaD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1A1—kidney cancer	0.00027	0.00386	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000265	0.0038	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—ALDH1A1—kidney cancer	0.000265	0.00379	CbGpPWpGaD
Felbamate—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000254	0.00364	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—TSC2—kidney cancer	0.000248	0.00355	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000248	0.00355	CbGpPWpGaD
Felbamate—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000244	0.00349	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HNF1B—kidney cancer	0.00024	0.00343	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BCHE—kidney cancer	0.000238	0.00341	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK3—kidney cancer	0.000236	0.00338	CbGpPWpGaD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000234	0.00336	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000231	0.00331	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK1—kidney cancer	0.000224	0.00321	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000224	0.00321	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—APC—kidney cancer	0.000219	0.00314	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000218	0.00312	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000215	0.00308	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000212	0.00303	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.000211	0.00302	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000207	0.00296	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—ALDH1A1—kidney cancer	0.000204	0.00292	CbGpPWpGaD
Felbamate—Fatigue—Vincristine—kidney cancer	0.000202	0.000374	CcSEcCtD
Felbamate—Rash—Erlotinib—kidney cancer	0.000201	0.000374	CcSEcCtD
Felbamate—Dermatitis—Erlotinib—kidney cancer	0.000201	0.000373	CcSEcCtD
Felbamate—Palpitations—Paclitaxel—kidney cancer	0.000201	0.000373	CcSEcCtD
Felbamate—Hyponatraemia—Doxorubicin—kidney cancer	0.000201	0.000372	CcSEcCtD
Felbamate—Insomnia—Gemcitabine—kidney cancer	0.000201	0.000372	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—MAPK3—kidney cancer	0.0002	0.00287	CbGpPWpGaD
Felbamate—Headache—Erlotinib—kidney cancer	0.0002	0.000371	CcSEcCtD
Felbamate—Constipation—Vincristine—kidney cancer	0.0002	0.000371	CcSEcCtD
Felbamate—Pain—Vincristine—kidney cancer	0.0002	0.000371	CcSEcCtD
Felbamate—Osteoarthritis—Doxorubicin—kidney cancer	0.0002	0.000371	CcSEcCtD
Felbamate—Diplopia—Doxorubicin—kidney cancer	0.0002	0.000371	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—PAK1—kidney cancer	0.0002	0.00286	CbGpPWpGaD
Felbamate—Paraesthesia—Gemcitabine—kidney cancer	0.000199	0.00037	CcSEcCtD
Felbamate—Flushing—Capecitabine—kidney cancer	0.000199	0.00037	CcSEcCtD
Felbamate—Cough—Paclitaxel—kidney cancer	0.000199	0.000369	CcSEcCtD
Felbamate—Asthenia—Sunitinib—kidney cancer	0.000198	0.000368	CcSEcCtD
Felbamate—Dyspnoea—Gemcitabine—kidney cancer	0.000198	0.000367	CcSEcCtD
Felbamate—Nausea—Vinblastine—kidney cancer	0.000197	0.000366	CcSEcCtD
Felbamate—Somnolence—Gemcitabine—kidney cancer	0.000197	0.000366	CcSEcCtD
Felbamate—Affect lability—Doxorubicin—kidney cancer	0.000197	0.000365	CcSEcCtD
Felbamate—Migraine—Doxorubicin—kidney cancer	0.000197	0.000365	CcSEcCtD
Felbamate—Nausea—Everolimus—kidney cancer	0.000197	0.000365	CcSEcCtD
Felbamate—Diarrhoea—Sorafenib—kidney cancer	0.000197	0.000365	CcSEcCtD
Felbamate—Hypertension—Paclitaxel—kidney cancer	0.000196	0.000365	CcSEcCtD
Felbamate—Pruritus—Sunitinib—kidney cancer	0.000196	0.000363	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000195	0.00279	CbGpPWpGaD
Felbamate—Myalgia—Paclitaxel—kidney cancer	0.000194	0.00036	CcSEcCtD
Felbamate—Chest pain—Paclitaxel—kidney cancer	0.000194	0.00036	CcSEcCtD
Felbamate—Arthralgia—Paclitaxel—kidney cancer	0.000194	0.00036	CcSEcCtD
Felbamate—Anxiety—Paclitaxel—kidney cancer	0.000193	0.000358	CcSEcCtD
Felbamate—Face oedema—Doxorubicin—kidney cancer	0.000193	0.000358	CcSEcCtD
Felbamate—Decreased appetite—Gemcitabine—kidney cancer	0.000193	0.000358	CcSEcCtD
Felbamate—Chills—Capecitabine—kidney cancer	0.000192	0.000357	CcSEcCtD
Felbamate—Discomfort—Paclitaxel—kidney cancer	0.000191	0.000355	CcSEcCtD
Felbamate—Fatigue—Gemcitabine—kidney cancer	0.000191	0.000355	CcSEcCtD
Felbamate—Gastrointestinal pain—Vincristine—kidney cancer	0.000191	0.000355	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—MAPK1—kidney cancer	0.000191	0.00273	CbGpPWpGaD
Felbamate—Cardiac arrest—Doxorubicin—kidney cancer	0.00019	0.000353	CcSEcCtD
Felbamate—Dizziness—Sorafenib—kidney cancer	0.00019	0.000353	CcSEcCtD
Felbamate—Constipation—Gemcitabine—kidney cancer	0.00019	0.000352	CcSEcCtD
Felbamate—Pain—Gemcitabine—kidney cancer	0.00019	0.000352	CcSEcCtD
Felbamate—Nausea—Erlotinib—kidney cancer	0.00019	0.000352	CcSEcCtD
Felbamate—Alopecia—Capecitabine—kidney cancer	0.00019	0.000352	CcSEcCtD
Felbamate—Dry mouth—Paclitaxel—kidney cancer	0.000189	0.000352	CcSEcCtD
Felbamate—Mood swings—Doxorubicin—kidney cancer	0.000189	0.000351	CcSEcCtD
Felbamate—Diarrhoea—Sunitinib—kidney cancer	0.000189	0.000351	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TP53—kidney cancer	0.000188	0.0027	CbGpPWpGaD
Felbamate—Ataxia—Doxorubicin—kidney cancer	0.000188	0.000349	CcSEcCtD
Felbamate—Asthenia—Dactinomycin—kidney cancer	0.000188	0.000349	CcSEcCtD
Felbamate—Confusional state—Paclitaxel—kidney cancer	0.000187	0.000348	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000186	0.00267	CbGpPWpGaD
Felbamate—Dehydration—Doxorubicin—kidney cancer	0.000186	0.000345	CcSEcCtD
Felbamate—Oedema—Paclitaxel—kidney cancer	0.000186	0.000345	CcSEcCtD
Felbamate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000186	0.000345	CcSEcCtD
Felbamate—Abdominal pain—Vincristine—kidney cancer	0.000185	0.000343	CcSEcCtD
Felbamate—Body temperature increased—Vincristine—kidney cancer	0.000185	0.000343	CcSEcCtD
Felbamate—Infection—Paclitaxel—kidney cancer	0.000184	0.000342	CcSEcCtD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—kidney cancer	0.000184	0.00264	CbGpPWpGaD
Felbamate—Flatulence—Capecitabine—kidney cancer	0.000184	0.000342	CcSEcCtD
Felbamate—Dysgeusia—Capecitabine—kidney cancer	0.000183	0.000339	CcSEcCtD
Felbamate—Dizziness—Sunitinib—kidney cancer	0.000183	0.000339	CcSEcCtD
Felbamate—Feeling abnormal—Gemcitabine—kidney cancer	0.000183	0.000339	CcSEcCtD
Felbamate—Vomiting—Sorafenib—kidney cancer	0.000183	0.000339	CcSEcCtD
Felbamate—Hypokalaemia—Doxorubicin—kidney cancer	0.000182	0.000338	CcSEcCtD
Felbamate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000182	0.000338	CcSEcCtD
Felbamate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000182	0.0026	CbGpPWpGaD
Felbamate—Tachycardia—Paclitaxel—kidney cancer	0.000181	0.000336	CcSEcCtD
Felbamate—Rash—Sorafenib—kidney cancer	0.000181	0.000336	CcSEcCtD
Felbamate—Dermatitis—Sorafenib—kidney cancer	0.000181	0.000336	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.00018	0.000334	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00018	0.000334	CcSEcCtD
Felbamate—Headache—Sorafenib—kidney cancer	0.00018	0.000334	CcSEcCtD
Felbamate—Hyperhidrosis—Paclitaxel—kidney cancer	0.00018	0.000333	CcSEcCtD
Felbamate—Diarrhoea—Dactinomycin—kidney cancer	0.000179	0.000332	CcSEcCtD
Felbamate—Anorexia—Paclitaxel—kidney cancer	0.000177	0.000329	CcSEcCtD
Felbamate—Gastritis—Doxorubicin—kidney cancer	0.000177	0.000328	CcSEcCtD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000177	0.00253	CbGpPWpGaD
Felbamate—Muscular weakness—Doxorubicin—kidney cancer	0.000176	0.000327	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000176	0.000327	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000176	0.00252	CbGpPWpGaD
Felbamate—Vomiting—Sunitinib—kidney cancer	0.000176	0.000326	CcSEcCtD
Felbamate—Body temperature increased—Gemcitabine—kidney cancer	0.000175	0.000325	CcSEcCtD
Felbamate—Tremor—Capecitabine—kidney cancer	0.000175	0.000325	CcSEcCtD
Felbamate—Rash—Sunitinib—kidney cancer	0.000174	0.000324	CcSEcCtD
Felbamate—Dermatitis—Sunitinib—kidney cancer	0.000174	0.000323	CcSEcCtD
Felbamate—Hypotension—Paclitaxel—kidney cancer	0.000174	0.000322	CcSEcCtD
Felbamate—Ill-defined disorder—Capecitabine—kidney cancer	0.000173	0.000322	CcSEcCtD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000173	0.00248	CbGpPWpGaD
Felbamate—Headache—Sunitinib—kidney cancer	0.000173	0.000321	CcSEcCtD
Felbamate—Dysphagia—Doxorubicin—kidney cancer	0.000173	0.000321	CcSEcCtD
Felbamate—Asthma—Doxorubicin—kidney cancer	0.000173	0.000321	CcSEcCtD
Felbamate—Anaemia—Capecitabine—kidney cancer	0.000173	0.00032	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—RAF1—kidney cancer	0.000172	0.00246	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CTNNA1—kidney cancer	0.000172	0.00246	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—RELA—kidney cancer	0.000171	0.00245	CbGpPWpGaD
Felbamate—Eosinophilia—Doxorubicin—kidney cancer	0.000171	0.000317	CcSEcCtD
Felbamate—Nausea—Sorafenib—kidney cancer	0.000171	0.000317	CcSEcCtD
Felbamate—Pancreatitis—Doxorubicin—kidney cancer	0.000169	0.000314	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000169	0.000314	CcSEcCtD
Felbamate—Malaise—Capecitabine—kidney cancer	0.000168	0.000313	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000168	0.00241	CbGpPWpGaD
Felbamate—Insomnia—Paclitaxel—kidney cancer	0.000168	0.000312	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—MTOR—kidney cancer	0.000168	0.00241	CbGpPWpGaD
Felbamate—Asthenia—Vincristine—kidney cancer	0.000168	0.000311	CcSEcCtD
Felbamate—Leukopenia—Capecitabine—kidney cancer	0.000167	0.00031	CcSEcCtD
Felbamate—Paraesthesia—Paclitaxel—kidney cancer	0.000167	0.00031	CcSEcCtD
Felbamate—Vomiting—Dactinomycin—kidney cancer	0.000166	0.000309	CcSEcCtD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000166	0.00238	CbGpPWpGaD
Felbamate—Dyspnoea—Paclitaxel—kidney cancer	0.000166	0.000307	CcSEcCtD
Felbamate—Somnolence—Paclitaxel—kidney cancer	0.000165	0.000306	CcSEcCtD
Felbamate—Palpitations—Capecitabine—kidney cancer	0.000165	0.000306	CcSEcCtD
Felbamate—Rash—Dactinomycin—kidney cancer	0.000165	0.000306	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—PAX6—kidney cancer	0.000164	0.00236	CbGpPWpGaD
Felbamate—Nausea—Sunitinib—kidney cancer	0.000164	0.000305	CcSEcCtD
Felbamate—Pancytopenia—Doxorubicin—kidney cancer	0.000164	0.000305	CcSEcCtD
Felbamate—Dyspepsia—Paclitaxel—kidney cancer	0.000163	0.000303	CcSEcCtD
Felbamate—Cough—Capecitabine—kidney cancer	0.000163	0.000302	CcSEcCtD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000163	0.00233	CbGpPWpGaD
Felbamate—Dysuria—Doxorubicin—kidney cancer	0.000162	0.0003	CcSEcCtD
Felbamate—Decreased appetite—Paclitaxel—kidney cancer	0.000161	0.0003	CcSEcCtD
Felbamate—Hypertension—Capecitabine—kidney cancer	0.000161	0.000299	CcSEcCtD
Felbamate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000161	0.000298	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—TP53—kidney cancer	0.00016	0.00229	CbGpPWpGaD
Felbamate—Fatigue—Paclitaxel—kidney cancer	0.00016	0.000297	CcSEcCtD
Felbamate—Diarrhoea—Vincristine—kidney cancer	0.00016	0.000297	CcSEcCtD
Felbamate—Asthenia—Gemcitabine—kidney cancer	0.000159	0.000295	CcSEcCtD
Felbamate—Chest pain—Capecitabine—kidney cancer	0.000159	0.000295	CcSEcCtD
Felbamate—Arthralgia—Capecitabine—kidney cancer	0.000159	0.000295	CcSEcCtD
Felbamate—Myalgia—Capecitabine—kidney cancer	0.000159	0.000295	CcSEcCtD
Felbamate—Constipation—Paclitaxel—kidney cancer	0.000159	0.000295	CcSEcCtD
Felbamate—Pain—Paclitaxel—kidney cancer	0.000159	0.000295	CcSEcCtD
Felbamate—Anxiety—Capecitabine—kidney cancer	0.000158	0.000294	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000158	0.00227	CbGpPWpGaD
Felbamate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000158	0.000293	CcSEcCtD
Felbamate—Weight increased—Doxorubicin—kidney cancer	0.000157	0.000292	CcSEcCtD
Felbamate—Discomfort—Capecitabine—kidney cancer	0.000157	0.000292	CcSEcCtD
Felbamate—Pruritus—Gemcitabine—kidney cancer	0.000157	0.000291	CcSEcCtD
Felbamate—Weight decreased—Doxorubicin—kidney cancer	0.000156	0.00029	CcSEcCtD
Felbamate—Hyperglycaemia—Doxorubicin—kidney cancer	0.000156	0.000289	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000156	0.00223	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTT1—kidney cancer	0.000156	0.00223	CbGpPWpGaD
Felbamate—Dry mouth—Capecitabine—kidney cancer	0.000155	0.000289	CcSEcCtD
Felbamate—Nausea—Dactinomycin—kidney cancer	0.000155	0.000289	CcSEcCtD
Felbamate—Pneumonia—Doxorubicin—kidney cancer	0.000155	0.000288	CcSEcCtD
Felbamate—Dizziness—Vincristine—kidney cancer	0.000155	0.000287	CcSEcCtD
Felbamate—Confusional state—Capecitabine—kidney cancer	0.000154	0.000285	CcSEcCtD
Felbamate—Feeling abnormal—Paclitaxel—kidney cancer	0.000153	0.000284	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000153	0.000283	CcSEcCtD
Felbamate—Oedema—Capecitabine—kidney cancer	0.000152	0.000283	CcSEcCtD
Felbamate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000152	0.000282	CcSEcCtD
Felbamate—Diarrhoea—Gemcitabine—kidney cancer	0.000152	0.000282	CcSEcCtD
Felbamate—Infection—Capecitabine—kidney cancer	0.000151	0.000281	CcSEcCtD
Felbamate—Jaundice—Doxorubicin—kidney cancer	0.00015	0.000279	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—JUN—kidney cancer	0.00015	0.00215	CbGpPWpGaD
Felbamate—Urinary tract infection—Doxorubicin—kidney cancer	0.00015	0.000278	CcSEcCtD
Felbamate—Conjunctivitis—Doxorubicin—kidney cancer	0.00015	0.000278	CcSEcCtD
Felbamate—Thrombocytopenia—Capecitabine—kidney cancer	0.000149	0.000277	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—CTNNB1—kidney cancer	0.000149	0.00213	CbGpPWpGaD
Felbamate—Tachycardia—Capecitabine—kidney cancer	0.000149	0.000276	CcSEcCtD
Felbamate—Vomiting—Vincristine—kidney cancer	0.000149	0.000276	CcSEcCtD
Felbamate—Sweating—Doxorubicin—kidney cancer	0.000148	0.000274	CcSEcCtD
Felbamate—Urticaria—Paclitaxel—kidney cancer	0.000148	0.000274	CcSEcCtD
Felbamate—Rash—Vincristine—kidney cancer	0.000147	0.000274	CcSEcCtD
Felbamate—Hyperhidrosis—Capecitabine—kidney cancer	0.000147	0.000273	CcSEcCtD
Felbamate—Dermatitis—Vincristine—kidney cancer	0.000147	0.000273	CcSEcCtD
Felbamate—Haematuria—Doxorubicin—kidney cancer	0.000147	0.000273	CcSEcCtD
Felbamate—Abdominal pain—Paclitaxel—kidney cancer	0.000147	0.000272	CcSEcCtD
Felbamate—Body temperature increased—Paclitaxel—kidney cancer	0.000147	0.000272	CcSEcCtD
Felbamate—Headache—Vincristine—kidney cancer	0.000146	0.000272	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—PTGS1—kidney cancer	0.000146	0.00209	CbGpPWpGaD
Felbamate—Epistaxis—Doxorubicin—kidney cancer	0.000145	0.00027	CcSEcCtD
Felbamate—Anorexia—Capecitabine—kidney cancer	0.000145	0.00027	CcSEcCtD
Felbamate—Sinusitis—Doxorubicin—kidney cancer	0.000145	0.000268	CcSEcCtD
Felbamate—Agranulocytosis—Doxorubicin—kidney cancer	0.000144	0.000267	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—BRAF—kidney cancer	0.000143	0.00204	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PAK1—kidney cancer	0.000143	0.00204	CbGpPWpGaD
Felbamate—Hypotension—Capecitabine—kidney cancer	0.000142	0.000264	CcSEcCtD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000142	0.00203	CbGpPWpGaD
Felbamate—Vomiting—Gemcitabine—kidney cancer	0.000141	0.000262	CcSEcCtD
Felbamate—Bradycardia—Doxorubicin—kidney cancer	0.000141	0.000261	CcSEcCtD
Felbamate—Rash—Gemcitabine—kidney cancer	0.00014	0.00026	CcSEcCtD
Felbamate—Dermatitis—Gemcitabine—kidney cancer	0.00014	0.000259	CcSEcCtD
Felbamate—Haemoglobin—Doxorubicin—kidney cancer	0.000139	0.000258	CcSEcCtD
Felbamate—Headache—Gemcitabine—kidney cancer	0.000139	0.000258	CcSEcCtD
Felbamate—Nausea—Vincristine—kidney cancer	0.000139	0.000258	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000139	0.000258	CcSEcCtD
Felbamate—Rhinitis—Doxorubicin—kidney cancer	0.000139	0.000257	CcSEcCtD
Felbamate—Hepatitis—Doxorubicin—kidney cancer	0.000138	0.000257	CcSEcCtD
Felbamate—Haemorrhage—Doxorubicin—kidney cancer	0.000138	0.000257	CcSEcCtD
Felbamate—Insomnia—Capecitabine—kidney cancer	0.000138	0.000256	CcSEcCtD
Felbamate—Pharyngitis—Doxorubicin—kidney cancer	0.000137	0.000255	CcSEcCtD
Felbamate—Paraesthesia—Capecitabine—kidney cancer	0.000137	0.000254	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.000136	0.00195	CbGpPWpGaD
Felbamate—Dyspnoea—Capecitabine—kidney cancer	0.000136	0.000252	CcSEcCtD
Felbamate—Dyspepsia—Capecitabine—kidney cancer	0.000134	0.000249	CcSEcCtD
Felbamate—Visual impairment—Doxorubicin—kidney cancer	0.000133	0.000247	CcSEcCtD
Felbamate—Asthenia—Paclitaxel—kidney cancer	0.000133	0.000247	CcSEcCtD
Felbamate—Decreased appetite—Capecitabine—kidney cancer	0.000132	0.000246	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000132	0.00189	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000132	0.00189	CbGpPWpGaD
Felbamate—Nausea—Gemcitabine—kidney cancer	0.000132	0.000245	CcSEcCtD
Felbamate—Fatigue—Capecitabine—kidney cancer	0.000131	0.000244	CcSEcCtD
Felbamate—Pruritus—Paclitaxel—kidney cancer	0.000131	0.000244	CcSEcCtD
Felbamate—Erythema multiforme—Doxorubicin—kidney cancer	0.000131	0.000243	CcSEcCtD
Felbamate—Constipation—Capecitabine—kidney cancer	0.00013	0.000242	CcSEcCtD
Felbamate—Pain—Capecitabine—kidney cancer	0.00013	0.000242	CcSEcCtD
Felbamate—Flushing—Doxorubicin—kidney cancer	0.000128	0.000238	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000127	0.00182	CbGpPWpGaD
Felbamate—Diarrhoea—Paclitaxel—kidney cancer	0.000127	0.000236	CcSEcCtD
Felbamate—Feeling abnormal—Capecitabine—kidney cancer	0.000126	0.000233	CcSEcCtD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000125	0.0018	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000125	0.00179	CbGpPWpGaD
Felbamate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000125	0.000231	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—KDR—kidney cancer	0.000124	0.00178	CbGpPWpGaD
Felbamate—Chills—Doxorubicin—kidney cancer	0.000124	0.00023	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK3—kidney cancer	0.000124	0.00178	CbGpPWpGaD
Felbamate—Dizziness—Paclitaxel—kidney cancer	0.000123	0.000228	CcSEcCtD
Felbamate—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000123	0.00176	CbGpPWpGaD
Felbamate—Alopecia—Doxorubicin—kidney cancer	0.000122	0.000227	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—MET—kidney cancer	0.000122	0.00174	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BRAF—kidney cancer	0.000121	0.00174	CbGpPWpGaD
Felbamate—Urticaria—Capecitabine—kidney cancer	0.000121	0.000225	CcSEcCtD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	0.000121	0.00173	CbGpPWpGaD
Felbamate—Body temperature increased—Capecitabine—kidney cancer	0.00012	0.000224	CcSEcCtD
Felbamate—Abdominal pain—Capecitabine—kidney cancer	0.00012	0.000224	CcSEcCtD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—kidney cancer	0.00012	0.00172	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTT1—kidney cancer	0.00012	0.00172	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—RAF1—kidney cancer	0.000119	0.00171	CbGpPWpGaD
Felbamate—Flatulence—Doxorubicin—kidney cancer	0.000119	0.00022	CcSEcCtD
Felbamate—Tension—Doxorubicin—kidney cancer	0.000118	0.000219	CcSEcCtD
Felbamate—Vomiting—Paclitaxel—kidney cancer	0.000118	0.000219	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK1—kidney cancer	0.000118	0.00169	CbGpPWpGaD
Felbamate—Dysgeusia—Doxorubicin—kidney cancer	0.000118	0.000219	CcSEcCtD
Felbamate—Rash—Paclitaxel—kidney cancer	0.000117	0.000217	CcSEcCtD
Felbamate—Dermatitis—Paclitaxel—kidney cancer	0.000117	0.000217	CcSEcCtD
Felbamate—Nervousness—Doxorubicin—kidney cancer	0.000117	0.000217	CcSEcCtD
Felbamate—Headache—Paclitaxel—kidney cancer	0.000116	0.000216	CcSEcCtD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000116	0.00166	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—PTGS1—kidney cancer	0.000112	0.00161	CbGpPWpGaD
Felbamate—Ill-defined disorder—Doxorubicin—kidney cancer	0.000112	0.000207	CcSEcCtD
Felbamate—Anaemia—Doxorubicin—kidney cancer	0.000111	0.000207	CcSEcCtD
Felbamate—Agitation—Doxorubicin—kidney cancer	0.000111	0.000205	CcSEcCtD
Felbamate—Nausea—Paclitaxel—kidney cancer	0.00011	0.000205	CcSEcCtD
Felbamate—Asthenia—Capecitabine—kidney cancer	0.000109	0.000203	CcSEcCtD
Felbamate—Malaise—Doxorubicin—kidney cancer	0.000109	0.000201	CcSEcCtD
Felbamate—Pruritus—Capecitabine—kidney cancer	0.000108	0.0002	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—GSTP1—kidney cancer	0.000108	0.00154	CbGpPWpGaD
Felbamate—Leukopenia—Doxorubicin—kidney cancer	0.000108	0.0002	CcSEcCtD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000107	0.00153	CbGpPWpGaD
Felbamate—Palpitations—Doxorubicin—kidney cancer	0.000106	0.000197	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—GSTP1—kidney cancer	0.000106	0.00152	CbGpPWpGaD
Felbamate—Cough—Doxorubicin—kidney cancer	0.000105	0.000195	CcSEcCtD
Felbamate—Diarrhoea—Capecitabine—kidney cancer	0.000104	0.000194	CcSEcCtD
Felbamate—Hypertension—Doxorubicin—kidney cancer	0.000104	0.000193	CcSEcCtD
Felbamate—Myalgia—Doxorubicin—kidney cancer	0.000102	0.00019	CcSEcCtD
Felbamate—Chest pain—Doxorubicin—kidney cancer	0.000102	0.00019	CcSEcCtD
Felbamate—Arthralgia—Doxorubicin—kidney cancer	0.000102	0.00019	CcSEcCtD
Felbamate—Anxiety—Doxorubicin—kidney cancer	0.000102	0.00019	CcSEcCtD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000102	0.00146	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—RAF1—kidney cancer	0.000101	0.00145	CbGpPWpGaD
Felbamate—Discomfort—Doxorubicin—kidney cancer	0.000101	0.000188	CcSEcCtD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000101	0.00145	CbGpPWpGaD
Felbamate—Dizziness—Capecitabine—kidney cancer	0.000101	0.000187	CcSEcCtD
Felbamate—Dry mouth—Doxorubicin—kidney cancer	0.0001	0.000186	CcSEcCtD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.99e-05	0.00143	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	9.92e-05	0.00142	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTM1—kidney cancer	9.91e-05	0.00142	CbGpPWpGaD
Felbamate—Confusional state—Doxorubicin—kidney cancer	9.91e-05	0.000184	CcSEcCtD
Felbamate—Oedema—Doxorubicin—kidney cancer	9.82e-05	0.000182	CcSEcCtD
Felbamate—Anaphylactic shock—Doxorubicin—kidney cancer	9.82e-05	0.000182	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—GSTM1—kidney cancer	9.77e-05	0.0014	CbGpPWpGaD
Felbamate—Infection—Doxorubicin—kidney cancer	9.76e-05	0.000181	CcSEcCtD
Felbamate—Vomiting—Capecitabine—kidney cancer	9.69e-05	0.00018	CcSEcCtD
Felbamate—Thrombocytopenia—Doxorubicin—kidney cancer	9.62e-05	0.000179	CcSEcCtD
Felbamate—Rash—Capecitabine—kidney cancer	9.61e-05	0.000178	CcSEcCtD
Felbamate—Dermatitis—Capecitabine—kidney cancer	9.6e-05	0.000178	CcSEcCtD
Felbamate—Tachycardia—Doxorubicin—kidney cancer	9.59e-05	0.000178	CcSEcCtD
Felbamate—Headache—Capecitabine—kidney cancer	9.55e-05	0.000177	CcSEcCtD
Felbamate—Hyperhidrosis—Doxorubicin—kidney cancer	9.5e-05	0.000176	CcSEcCtD
Felbamate—CYP2E1—Biological oxidations—CYP1A1—kidney cancer	9.39e-05	0.00134	CbGpPWpGaD
Felbamate—Anorexia—Doxorubicin—kidney cancer	9.36e-05	0.000174	CcSEcCtD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A1—kidney cancer	9.26e-05	0.00133	CbGpPWpGaD
Felbamate—Hypotension—Doxorubicin—kidney cancer	9.18e-05	0.00017	CcSEcCtD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MAPK1—kidney cancer	9.07e-05	0.0013	CbGpPWpGaD
Felbamate—Nausea—Capecitabine—kidney cancer	9.05e-05	0.000168	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—RAF1—kidney cancer	8.99e-05	0.00129	CbGpPWpGaD
Felbamate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.95e-05	0.000166	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—ERBB2—kidney cancer	8.9e-05	0.00127	CbGpPWpGaD
Felbamate—Insomnia—Doxorubicin—kidney cancer	8.89e-05	0.000165	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—KDR—kidney cancer	8.88e-05	0.00127	CbGpPWpGaD
Felbamate—Paraesthesia—Doxorubicin—kidney cancer	8.82e-05	0.000164	CcSEcCtD
Felbamate—Dyspnoea—Doxorubicin—kidney cancer	8.76e-05	0.000163	CcSEcCtD
Felbamate—Somnolence—Doxorubicin—kidney cancer	8.73e-05	0.000162	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—MET—kidney cancer	8.69e-05	0.00124	CbGpPWpGaD
Felbamate—Dyspepsia—Doxorubicin—kidney cancer	8.65e-05	0.000161	CcSEcCtD
Felbamate—Decreased appetite—Doxorubicin—kidney cancer	8.54e-05	0.000159	CcSEcCtD
Felbamate—Fatigue—Doxorubicin—kidney cancer	8.47e-05	0.000157	CcSEcCtD
Felbamate—Constipation—Doxorubicin—kidney cancer	8.4e-05	0.000156	CcSEcCtD
Felbamate—Pain—Doxorubicin—kidney cancer	8.4e-05	0.000156	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTP1—kidney cancer	8.32e-05	0.00119	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACY1—kidney cancer	8.26e-05	0.00118	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTP1—kidney cancer	8.2e-05	0.00117	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.2e-05	0.00117	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MAPK1—kidney cancer	8.18e-05	0.00117	CbGpPWpGaD
Felbamate—Feeling abnormal—Doxorubicin—kidney cancer	8.1e-05	0.00015	CcSEcCtD
Felbamate—Gastrointestinal pain—Doxorubicin—kidney cancer	8.03e-05	0.000149	CcSEcCtD
Felbamate—Urticaria—Doxorubicin—kidney cancer	7.8e-05	0.000145	CcSEcCtD
Felbamate—Abdominal pain—Doxorubicin—kidney cancer	7.77e-05	0.000144	CcSEcCtD
Felbamate—Body temperature increased—Doxorubicin—kidney cancer	7.77e-05	0.000144	CcSEcCtD
Felbamate—CYP2C19—Biological oxidations—GSTM1—kidney cancer	7.64e-05	0.00109	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.54e-05	0.00108	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	7.54e-05	0.00108	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	7.25e-05	0.00104	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTT1—kidney cancer	7.22e-05	0.00103	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	7.15e-05	0.00102	CbGpPWpGaD
Felbamate—Asthenia—Doxorubicin—kidney cancer	7.05e-05	0.000131	CcSEcCtD
Felbamate—CYP2E1—Metabolism—PDHB—kidney cancer	7.02e-05	0.00101	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—POMC—kidney cancer	7e-05	0.001	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MAPK1—kidney cancer	6.95e-05	0.000995	CbGpPWpGaD
Felbamate—Pruritus—Doxorubicin—kidney cancer	6.95e-05	0.000129	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—VEGFA—kidney cancer	6.85e-05	0.000981	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—PTGS1—kidney cancer	6.76e-05	0.000968	CbGpPWpGaD
Felbamate—Diarrhoea—Doxorubicin—kidney cancer	6.72e-05	0.000125	CcSEcCtD
Felbamate—CYP2E1—Metabolism—CCBL1—kidney cancer	6.6e-05	0.000946	CbGpPWpGaD
Felbamate—Dizziness—Doxorubicin—kidney cancer	6.5e-05	0.000121	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—MAPK3—kidney cancer	6.48e-05	0.000928	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—RAF1—kidney cancer	6.42e-05	0.000919	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—RELA—kidney cancer	6.39e-05	0.000915	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACY1—kidney cancer	6.37e-05	0.000913	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—ERBB2—kidney cancer	6.35e-05	0.000909	CbGpPWpGaD
Felbamate—Vomiting—Doxorubicin—kidney cancer	6.25e-05	0.000116	CcSEcCtD
Felbamate—Rash—Doxorubicin—kidney cancer	6.19e-05	0.000115	CcSEcCtD
Felbamate—Dermatitis—Doxorubicin—kidney cancer	6.19e-05	0.000115	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—MAPK1—kidney cancer	6.17e-05	0.000883	CbGpPWpGaD
Felbamate—Headache—Doxorubicin—kidney cancer	6.15e-05	0.000114	CcSEcCtD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.12e-05	0.000876	CbGpPWpGaD
Felbamate—Nausea—Doxorubicin—kidney cancer	5.84e-05	0.000108	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—KRAS—kidney cancer	5.83e-05	0.000834	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PPAT—kidney cancer	5.73e-05	0.00082	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GLIPR1—kidney cancer	5.73e-05	0.00082	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CTNNB1—kidney cancer	5.55e-05	0.000795	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.44e-05	0.000778	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PDHB—kidney cancer	5.42e-05	0.000776	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—POMC—kidney cancer	5.4e-05	0.000774	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APRT—kidney cancer	5.32e-05	0.000762	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—FH—kidney cancer	5.32e-05	0.000762	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CCBL1—kidney cancer	5.1e-05	0.00073	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPC3—kidney cancer	5.01e-05	0.000717	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5e-05	0.000716	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	4.93e-05	0.000706	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—kidney cancer	4.89e-05	0.0007	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CA2—kidney cancer	4.87e-05	0.000697	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALAD—kidney cancer	4.75e-05	0.000679	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ST3GAL2—kidney cancer	4.63e-05	0.000663	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK3—kidney cancer	4.63e-05	0.000662	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.61e-05	0.00066	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTM1—kidney cancer	4.6e-05	0.000658	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	4.53e-05	0.000649	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALDH1A1—kidney cancer	4.53e-05	0.000648	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GLIPR1—kidney cancer	4.42e-05	0.000633	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PPAT—kidney cancer	4.42e-05	0.000633	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK1—kidney cancer	4.4e-05	0.00063	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.36e-05	0.000625	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.36e-05	0.000624	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PGK1—kidney cancer	4.34e-05	0.000621	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC5A3—kidney cancer	4.34e-05	0.000621	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.32e-05	0.000618	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.3e-05	0.000615	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—LDHB—kidney cancer	4.26e-05	0.000609	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—KRAS—kidney cancer	4.16e-05	0.000595	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—FH—kidney cancer	4.11e-05	0.000588	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APRT—kidney cancer	4.11e-05	0.000588	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.01e-05	0.000575	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPC3—kidney cancer	3.86e-05	0.000553	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACY1—kidney cancer	3.83e-05	0.000549	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA2—kidney cancer	3.76e-05	0.000538	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CA9—kidney cancer	3.69e-05	0.000528	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALAD—kidney cancer	3.66e-05	0.000524	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ST3GAL2—kidney cancer	3.57e-05	0.000512	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALDH1A1—kidney cancer	3.49e-05	0.0005	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PGK1—kidney cancer	3.35e-05	0.000479	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC5A3—kidney cancer	3.35e-05	0.000479	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—LDHB—kidney cancer	3.28e-05	0.00047	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PDHB—kidney cancer	3.26e-05	0.000467	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—POMC—kidney cancer	3.25e-05	0.000465	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CRABP1—kidney cancer	3.14e-05	0.000449	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CCBL1—kidney cancer	3.06e-05	0.000439	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ITPR2—kidney cancer	2.92e-05	0.000418	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CA9—kidney cancer	2.85e-05	0.000408	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.78e-05	0.000398	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTT1—kidney cancer	2.66e-05	0.000381	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ACHE—kidney cancer	2.66e-05	0.000381	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.66e-05	0.00038	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PPAT—kidney cancer	2.66e-05	0.00038	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SCARB1—kidney cancer	2.52e-05	0.000361	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS1—kidney cancer	2.49e-05	0.000357	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APRT—kidney cancer	2.47e-05	0.000354	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—FH—kidney cancer	2.47e-05	0.000354	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PSMD7—kidney cancer	2.44e-05	0.00035	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CRABP1—kidney cancer	2.42e-05	0.000347	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPC3—kidney cancer	2.32e-05	0.000333	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BCHE—kidney cancer	2.32e-05	0.000332	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC5A5—kidney cancer	2.29e-05	0.000328	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA2—kidney cancer	2.26e-05	0.000323	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ITPR2—kidney cancer	2.25e-05	0.000322	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SLC2A1—kidney cancer	2.21e-05	0.000317	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALAD—kidney cancer	2.2e-05	0.000315	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.15e-05	0.000308	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.1e-05	0.000301	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.07e-05	0.000297	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ACHE—kidney cancer	2.05e-05	0.000294	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTT1—kidney cancer	2.05e-05	0.000294	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.01e-05	0.000288	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PGK1—kidney cancer	2.01e-05	0.000288	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—LDHB—kidney cancer	1.97e-05	0.000283	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SCARB1—kidney cancer	1.94e-05	0.000278	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS1—kidney cancer	1.92e-05	0.000275	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PSMD7—kidney cancer	1.89e-05	0.00027	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTP1—kidney cancer	1.84e-05	0.000264	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BCHE—kidney cancer	1.79e-05	0.000256	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC5A5—kidney cancer	1.77e-05	0.000253	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ABCB1—kidney cancer	1.75e-05	0.00025	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CA9—kidney cancer	1.71e-05	0.000245	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SLC2A1—kidney cancer	1.71e-05	0.000244	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—kidney cancer	1.69e-05	0.000243	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.65e-05	0.000237	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—kidney cancer	1.61e-05	0.00023	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CRABP1—kidney cancer	1.46e-05	0.000208	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.44e-05	0.000207	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTP1—kidney cancer	1.42e-05	0.000204	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ITPR2—kidney cancer	1.35e-05	0.000194	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ABCB1—kidney cancer	1.35e-05	0.000193	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—kidney cancer	1.31e-05	0.000187	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—kidney cancer	1.24e-05	0.000177	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTT1—kidney cancer	1.23e-05	0.000177	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ACHE—kidney cancer	1.23e-05	0.000177	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—POMC—kidney cancer	1.2e-05	0.000171	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SCARB1—kidney cancer	1.17e-05	0.000167	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS1—kidney cancer	1.16e-05	0.000166	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PSMD7—kidney cancer	1.13e-05	0.000162	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BCHE—kidney cancer	1.08e-05	0.000154	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.06e-05	0.000152	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.03e-05	0.000147	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.02e-05	0.000146	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—kidney cancer	9.55e-06	0.000137	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—POMC—kidney cancer	9.24e-06	0.000132	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTP1—kidney cancer	8.55e-06	0.000122	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—kidney cancer	8.33e-06	0.000119	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ABCB1—kidney cancer	8.1e-06	0.000116	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—kidney cancer	7.86e-06	0.000113	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—kidney cancer	7.45e-06	0.000107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—kidney cancer	7.37e-06	0.000106	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—kidney cancer	6.43e-06	9.2e-05	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—kidney cancer	5.88e-06	8.42e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—POMC—kidney cancer	5.56e-06	7.96e-05	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—kidney cancer	4.53e-06	6.49e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—kidney cancer	4.43e-06	6.35e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—kidney cancer	3.86e-06	5.53e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.73e-06	3.9e-05	CbGpPWpGaD
